1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
6C870157BF5F7208E002588220051AE6C
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/C870157BF5F7208E002588220051AE6C?OpenDocument
18
19OpenDocument
2018.208.126.232
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB




Products & Services Brand Management and Product Leadership Branding and Identity

Document Excerpt: Building Winning Trademarks and Trade Name Operations: Trade Name Generation, Structure, and Investment

DB Image

Excerpt in Cart

ID: MD-820


Features:

4 Info Graphics

12 Data Graphics

90+ Metrics


Pages/Slides: 4


Published: 2022


Delivery Format: Online PDF Document


 

License Options:


Download FREE Excerpt

 

919-403-0251

  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • SPECIAL OFFER
To download this excerpt, click "Download Free Excerpt".

To return to the study abstract to purchase the full study -
click here

This excerpt includes research findings and metrics from document #5720 “Building Winning Trademarks and Trade Name Operations: Trade Name Generation, Structure, and Investment”.

Industries Profiled:
Pharmaceutical; Biotech; Health Care; Chemical; Medical Device


Companies Profiled:
Astellas; CSL Behring; Ferring Pharmaceuticals; Fresenius Kabi; Gate Neurosciences; Inc.; Genentech; GlaxoSmithKline ; Medicago; Merck; Pfizer; Roche; Stada Arzneimittel AG; Teva Pharmaceutical Industries Ltd

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.